drugset / Trial / NCT02451098
Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Factorial Design, Phase III Clinical Trial.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-10
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | — |
| Subject | Atorvastatin | Small molecule | 20 mg | — |
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | Ezetimibe | Unknown | 10 mg | — |